A Novel and Expanding SARS-CoV-2 Variant, B.1.1.318, dominates infections in Mauritius

Houriiyah Tegally; Magalutcheemee Ramuth; Daniel Amoaka; Cathrine Scheepers; Eduan Wilkinson; Marta Giovanetti; Richard J Lessells; Jennifer Giandhari; Arshad Ismail; Darren Martin; Emmanuel James San; Margaret Crawford; Rodney S Daniels; Ruth Harvey; Somduthsingh Bahadoor; Janaki Sonoo; Myriam Timol; Lovena Veerapa-Mangroo; Anne von Gottberg; Jinal Bhiman; Tulio de Oliveira; Shyam Manraj.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21259017

Documentos relacionados

  1. Genomic reconstruction of the SARS-CoV-2 epidemic in England.
  2. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
  3. Context-specific emergence and growth of the SARS-CoV-2 Delta variant.
  4. Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern.
  5. Household quarantine of second degree contacts is an effective non-pharmaceutical intervention to prevent tertiary cases in the current SARS-CoV pandemic.
  6. Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.
  7. Genomic surveillance reveals the detection of SARS-CoV-2 delta, beta, and gamma VOCs during the third wave in Pakistan.
  8. Impact of pre-event testing and quarantine on reducing the risk of COVID-19 epidemic rebound: a modelling study.
  9. Pooled testing for SARS-CoV-2, options for efficiency at scale.
  10. A full genome tiling array enhanced the inspection and quarantine of SARS-CoV-2.